Teladoc Health Inc (TDOC) is the subject of today’s FOMO segment. In this segment Jenny Horne and Caroline Woods discuss the telehealth company’s 1Q earnings report and subsequent stock plunge on Thursday. Jenny discusses Teladoc’s competitors in the space including Zoom (ZM). Caroline reviews analysts’ downgrades of Teladoc (TDOC) and their reasons for doing so. Caroline also breaks down TDOC’s EPS -$41.01 miss and -$3.2M Revenue miss. Finally, Sean Cruz joins the conversation and demonstrates an example trade using shares of Teladoc (TDOC)
Next Gen Investing
29 Apr 2022
SHARE